20-year depressive symptoms, dementia, and structural neuropathology in older women
- PMID: 38591250
- PMCID: PMC11095467
- DOI: 10.1002/alz.13781
20-year depressive symptoms, dementia, and structural neuropathology in older women
Abstract
Introduction: The course of depressive symptoms and dementia risk is unclear, as are potential structural neuropathological common causes.
Methods: Utilizing joint latent class mixture models, we identified longitudinal trajectories of annually assessed depressive symptoms and dementia risk over 21 years in 957 older women (baseline age 72.7 years old) from the Women's Health Initiative Memory Study. In a subsample of 569 women who underwent structural magnetic resonance imaging, we examined whether estimates of cerebrovascular disease and Alzheimer's disease (AD)-related neurodegeneration were associated with identified trajectories.
Results: Five trajectories of depressive symptoms and dementia risk were identified. Compared to women with minimal symptoms, women who reported mild and stable and emerging depressive symptoms were at the highest risk of developing dementia and had more cerebrovascular disease and AD-related neurodegeneration.
Discussion: There are heterogeneous profiles of depressive symptoms and dementia risk. Common neuropathological factors may contribute to both depression and dementia. Highlights The progression of depressive symptoms and concurrent dementia risk is heterogeneous. Emerging depressive symptoms may be a prodromal symptom of dementia. Cerebrovascular disease and AD are potentially shared neuropathological factors.
Keywords: Alzheimer's disease neurodegeneration; cerebrovascular disease; dementia; depression; joint modeling; women.
© 2024 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
Conflict of interest statement
The authors have no conflicts of interest to disclose. Author disclosures are available in the supporting information.
Figures
References
-
- Mielke MM. Sex differences in CSF biomarkers of Alzheimer's disease. Sex and Gender Differences in Alzheimer's Disease. 2021:107‐123. doi:10.1016/b978-0-12-819344-0.00012-0 - DOI
-
- Biskup E, Jordan V, Nasta B, Rauen K. Sex differences in psychiatric disorders and their implication for dementia. Sex and Gender Differences in Alzheimer's Disease. 2021:187‐206. doi:10.1016/b978-0-12-819344-0.00005-3 - DOI
-
- Bennett S, Thomas AJ. Depression and dementia: cause, consequence or coincidence? Maturitas. 2014;79(2):184‐190. - PubMed
Publication types
MeSH terms
Grants and funding
- HHSN268201100001I/HL/NHLBI NIH HHS/United States
- P30 ES007048/ES/NIEHS NIH HHS/United States
- RF1 AG079149/AG/NIA NIH HHS/United States
- HHSN268201100046C/HL/NHLBI NIH HHS/United States
- P01AG055367/Wake Forest University
- P30 AG066530/AG/NIA NIH HHS/United States
- HHSN271201100004C/AG/NIA NIH HHS/United States
- HHSN268201100002C/WH/WHI NIH HHS/United States
- RF1AG054068/Wake Forest University
- RF1 AG074345/AG/NIA NIH HHS/United States
- HHSN268201100004C/WH/WHI NIH HHS/United States
- Wyeth Pharmaceuticals, St. Davids, PA, USA
- HHSN268201100004I/HL/NHLBI NIH HHS/United States
- R01 ES033961/ES/NIEHS NIH HHS/United States
- HHSN268201100003C/WH/WHI NIH HHS/United States
- R01 ES025888/ES/NIEHS NIH HHS/United States
- P01 AG055367/AG/NIA NIH HHS/United States
- RF1 AG054068/AG/NIA NIH HHS/United States
- R01 AG074345/AG/NIA NIH HHS/United States
- The Women's Health Initiative Study of Cognitive Aging
- R01 AG033078/AG/NIA NIH HHS/United States
- HHSN268201100003I/HL/NHLBI NIH HHS/United States
- HHSN268201100002I/HL/NHLBI NIH HHS/United States
- N01-AG-1-2106/Department of Health and Human Services and the National Institute on Aging
- P50A05142/Alzheimer's Disease Research Center at USC
- NIA
- R01ES025888/Wake Forest University
- R01AG033078/Wake Forest University
- HHSN268201100001C/WH/WHI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
